An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones (bibtex)

by Vehreschild, Maria J. G. T., Ducher, Annie, Louie, Thomas, Cornely, Oliver A., Feger, Celine, Dane, Aaron, Varastet, Marina, Vitry, Fabien, de Gunzburg, Jean, Andremont, Antoine, Mentré, France and Wilcox, Mark H.

Reference:

An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones (Vehreschild, Maria J. G. T., Ducher, Annie, Louie, Thomas, Cornely, Oliver A., Feger, Celine, Dane, Aaron, Varastet, Marina, Vitry, Fabien, de Gunzburg, Jean, Andremont, Antoine, Mentré, France and Wilcox, Mark H.), In J. Antimicrob. Chemoth., volume 77.

Bibtex Entry:

@Article{vehreschild2022a,
  Author          = {Vehreschild, Maria J. G. T. and Ducher, Annie and Louie,
                    Thomas and Cornely, Oliver A. and Feger, Celine and Dane,
                    Aaron and Varastet, Marina and Vitry, Fabien and de
                    Gunzburg, Jean and Andremont, Antoine and Mentré, France
                    and Wilcox, Mark H.},
  Title           = {An open randomized multicentre Phase 2 trial to assess
                    the safety of {DAV132} and its efficacy to protect gut
                    microbiota diversity in hospitalized patients treated
                    with fluoroquinolones},
  JournalTitle    = {J. Antimicrob. Chemoth.},
  Date            = {2022},
  DOI             = {10.1093/jac/dkab474},
  Keywords        = {Vehreschild-Selection},
  Number          = {4},
  Pages           = {1155--1165},
  Volume          = {77}
}